Zack is currently serving as a hematology/oncology medical science liaison (MSL) with Kyowa Kirin (primary focus in hematologic malignancies). His previous experience included supporting GSK Oncology in a similar liaison capacity. Prior to these field medical roles, Zack had a brief stint in medical writing with Vaniam Group (oncology-focused scientific communications). 

Zack’s first role after pharmacy school came as a clinical content position where he supported and helped to manage the College of American Pathologists (CAP) Cancer Protocols. He was able to work alongside pathologists and key opinion leaders (KOLs) who were cancer subspecialty experts and the authors of these protocols. The Cancer Protocols are used by pathologists worldwide as guidelines for collecting and reporting information on malignant tumor classification, histology, grading, staging, margins, nodal involvement, metastatic disease, biomarker profiles, etc. The Cancer Protocols serve as the gold standard in reporting for not only accreditation purposes but are also instrumental in driving the direction of care as a patient begins the journey from a cancer diagnosis to treatment and beyond.